Mar 05, 2024 / 06:30AM GMT
Sibongakonke Nkosi - Aspen Pharmacare Holdings Ltd - Investor Relations Manager
Good morning, ladies and gentlemen, in the room and those of you joining us via webcast today. It is my pleasure to welcome you to the financial results of the first six months of Aspen's results -- financial year, sorry. My name is Sibongakonke Nkosi, and I'm the Group Investor Relations Manager here at Aspen.
In today's proceedings, you'll be hearing from Stephen Saad, the Group Chief Executive, who will be providing you with insightful overview of our results, taking us through the revenue performance of the group and its segments. Notably, we have revised the segmental reporting, both in commercial pharma and manufacturing. These new segments give improved insights, understanding and more granular disclosure.
We've also bolstered the appendices to provide more detailed analysis inter alia in the appendices. You will find a comparison of the revenue disclosure between the old and the new reporting segments for commercial pharma and manufacturing.
Also included in the appendices is a table
Half Year 2024 Aspen Pharmacare Holdings Ltd Earnings Call Transcript
Mar 05, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers